期刊文献+

程序性细胞死亡因子4蛋白表达与喉鳞状细胞癌相关性研究 被引量:4

Expression of programmed cell death 4 protein is closely correlated with laryngeal squamous cell carcinomas
原文传递
导出
摘要 目的:探讨程序性细胞死亡因子4(PDCD4)与喉鳞状细胞癌发生和发展的关系。方法:免疫组织化学方法和Western印迹法检测喉鳞状细胞癌组织及癌旁正常喉黏膜组织中PDCD4蛋白表达。结果:免疫组织化学染色显示喉鳞状细胞癌组织中PDCD4蛋白阳性表达率低于癌旁正常喉黏膜组织,差异有统计学意义(P<0.01)。喉鳞状细胞癌组织中PDCD4蛋白阳性表达和患者的年龄、性别、临床分型(肿瘤部位)、TNM分期无相关性,与病理分级、淋巴结转移有显著相关性。免疫印迹结果亦显示喉鳞状细胞癌组织中PDCD4蛋白表达低于癌旁正常喉黏膜组织(P<0.01)。结论:PDCD4蛋白低表达与喉鳞状细胞癌的发生和发展有关,PDCD4可能成为预测喉鳞状细胞癌转移和预后的生物学指标。 Objective:To study whether programmed cell death 4(PDCD4) is involved in the development and progression of laryngeal squamous cell carcinomas(LSCC).Method:The expressions of PDCD4 protein were examined by immunohistochemical staining and Western blot in LSCC tissues and their surrouding laryngeal normoal mucosa tissues.Result:The positive rate of PDCD4 protein in LSCC was significantly lower than that in the laryngeal normoal mucosa tissues by immunohistochemical staining(P0.01).No correlation was found between positive expression of PDCD4 and gender,age,tumor site,TNM stage,but there was significant correlation between positive expression of PDCD4 from differentiation grading and lymphatic matastasis.Meanwhile,we got the similar results by Western blot(P0.01).Conclusion:The low expression of PDCD4 protein is closely related to the development and progression of LSCC.PDCD4 might be a novel molecular marker for prognosticating metastases and prognosis of LSCC.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2011年第12期539-541,共3页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 首都医科大学基础-临床科研合作基金项目(No:09JL-L09)
关键词 喉肿瘤 程序性细胞死亡因子4 免疫组织化学 鳞状细胞 laryngeal neoplasms programmed cell death 4 immunohistochemistry carcinoma squamous cell
  • 相关文献

参考文献9

  • 1LANKAT-BUTTGEREIT B, GOKE R. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation[J]. Biol Cell, 2009, 101: 309-317.
  • 2王建亭,龚树生,刘英鹏.蛋白激酶CK2α特异性siRNA对人喉癌裸鼠移植瘤的抑制作用[J].临床耳鼻咽喉头颈外科杂志,2009,23(6):267-270. 被引量:5
  • 3MOTOYAMA K, INOUE H, MIMORI K, et al. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer[J]. Int J Oncol,2010,36 : 1089-1095.
  • 4MUDDULURU G, MEDVED F, GROBHOLZ R, et al. Loss of programmed cell death 4 expression marks adenomacarcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer[J]. Cancer, 2007,110:1697-1707.
  • 5FASSAN M, CAQOL M, PENNEIAA G, et al. Programmed cell death 4 protein in esophageal cancer[J]. Oncol Rep,2010,24:135 - 139.
  • 6WANG X, WEI Z, GAO F, et al. Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma [J]. Anticancer Res, 2008, 28: 2991-2996.
  • 7YANG H S,KNIES J I.,STARK C,et al. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation[J]. Oncogene, 2003,22 : 3712 - 3720.
  • 8马刚,张浩,董明,郑新宇,尾崎岩太,松桥幸子,郭克建.程序性细胞死亡因子4在消化系统肿瘤中表达及其与肿瘤分化的关系[J].中华肿瘤防治杂志,2007,14(4):249-253. 被引量:9
  • 9HILLIARD A, HILLIARD B, ZHENG S J, et al. Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4 [J]. J Immunol,2006,177 :8095- 8102.

二级参考文献26

  • 1王建亭,龚树生,刘英鹏.蛋白激酶CK2α在喉鳞状细胞癌组织中的表达及临床意义[J].临床耳鼻咽喉科杂志,2006,20(9):412-414. 被引量:5
  • 2王建亭,龚树生,刘英鹏,陈广理.蛋白激酶CK2α特异性小干扰RNA对喉癌细胞生长的抑制作用[J].中华耳鼻咽喉头颈外科杂志,2006,41(8):617-621. 被引量:3
  • 3PINNA L A. Protein kinase CK2 : a challenge to can ons[J]. J CellSci,2002,115:3873--3878.
  • 4XU X, LANDESMAN-BOLLAG E, CHANNAVAJHALA P L, et al. Murine protein kinase CK2.. gene and oncogene[J]. Mol Cell Biochem, 1999,191: 65 -- 74.
  • 5LITCHFIELD D W. Protein CK2: structure, regulation and role in cellular decisions of life and death[J]. Biochem J,2003,369:1--15.
  • 6HAMMOND S M. Dicing and slicing: the core machinery of the RNA interference pathway[J]. FEBS Lett, 2005,579 : 5822 -- 5829.
  • 7DUXBURY M S,WHANG E E. RNA interference: a practical approach[J]. J Surg Res, 2004, 117:339 -- 344.
  • 8SCHERR M, MORGAN M A,EDER M. Gene silencing mediated by small interfering RNAs in mammalian cells[J]. Curr Med Chem, 2003,10 : 245 -- 256.
  • 9KALOTA A,DONDETI V R,GEWIRTZ A M. Progress in the development of nucleic acid therapeutics [J].Handb Exp Pharmacol, 2006 ,173 :173 -196.
  • 10AHME D. Nuclear matrix and protein kinase CK2 signaling[J]. Crit Rev Gene Express, 1999,9: 329-- 336.

共引文献12

同被引文献31

  • 1马刚,刘江,张浩,董明,郑新宇,尾崎岩太,松桥幸子,郭克建.程序性细胞死亡因子4在胃癌组织中的表达及临床病理学意义[J].中华肿瘤防治杂志,2006,13(7):481-484. 被引量:16
  • 2马刚 ,张浩 ,董明,郑新宇,尾崎岩太 ,松桥幸子 ,郭克建 .程序性细胞死亡因子4在大肠癌组织中表达的临床病理学意义及其与预后的关系[J].中华普通外科杂志,2007,22(1):67-68. 被引量:2
  • 3马刚,张浩,董明,郑新宇,尾崎岩太,松桥幸子,郭克建.大肠癌组织中PDCD4表达的临床病理学意义及其对预后的影响(英文)[J].中国现代医学杂志,2007,17(11):1281-1286. 被引量:4
  • 4LANKAT B,GOKE R.The tumour suppressor PD-CD4:recent advances in the elucidation of functionand regulation[J].Biol Cell,2009,101:309-317.
  • 5MOTOYAMA K,INOUE H,MIMORI K,et al.Clini-copathological and prognostic significance of PDCD4and microRNA-21in human gastric cancer[J].Int JOncol,2010,36:1089-1095.
  • 6MUDDULURU G,MEDVED F,GROBHOLZ R,etal.Loss of programmed cell death 4expression marksadenoma-carcinoma transition,correlates inverselywith phosphorylated protein kinase B,and is an inde-pendent prognostic factor in resected colorectal cancer[J].Cancer,2007,110:1697-1707.
  • 7FASSAN M,CAQOL M,PENNELLI G,et al.Pro-grammed cell death 4protein in esophageal cancer[J].Oncol Rep,2010,24:135-139.
  • 8WANG X,WEI Z,GAO F,et al.Expression and prog-nostic significance of PDCD4in human epithelial ovar-ian carcinoma[J].Anticancer Res,2008,28:2991-2996.
  • 9SUZUKI C,GARCES R G,EDMONDS K A,et al.PDCD4inhibits translation initiation by binding toeIF4Ausing both its MA3domains[J].Proc NatlAcad Sci USA,2008,105:3274-3279.
  • 10WATERS L C,VEVERKA V,BOHM M,et al.Struc-ture of the C-terminal MA-3domain of the tumor sup-pressor protein PDCD4and characterization of its in-teraction with eIF4A[J].Oncogene,2007,26:4941-4950.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部